A detailed history of Cary Street Partners Investment Advisory LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 25,826 shares of LLY stock, worth $20.5 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
25,826
Previous 25,841 0.06%
Holding current value
$20.5 Million
Previous $23.4 Million 2.2%
% of portfolio
0.87%
Previous 0.97%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$772.14 - $960.02 $11,582 - $14,400
-15 Reduced 0.06%
25,826 $22.9 Million
Q2 2024

Jul 22, 2024

SELL
$724.87 - $909.04 $289,948 - $363,616
-400 Reduced 1.52%
25,841 $23.4 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $307,351 - $411,193
-519 Reduced 1.94%
26,241 $20.4 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $9.53 Million - $11.2 Million
18,145 Added 210.62%
26,760 $15.6 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $9.15 Million - $10.8 Million
-17,414 Reduced 66.9%
8,615 $5.02 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $136,930 - $188,779
315 Added 1.23%
26,029 $14 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $543,647 - $726,919
-1,550 Reduced 5.69%
25,714 $12.1 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $180,786 - $212,325
-582 Reduced 2.09%
27,264 $9.36 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $257,240 - $299,736
-800 Reduced 2.79%
27,846 $10.2 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $555,010 - $632,492
1,872 Added 6.99%
28,646 $9.26 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $4.93 Million - $5.78 Million
17,676 Added 194.28%
26,774 $8.68 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $113,355 - $140,871
483 Added 5.61%
9,098 $2.61 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $76,449 - $94,873
340 Added 4.11%
8,615 $2.38 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $23,711 - $29,179
-107 Reduced 1.28%
8,275 $1.91 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $364,711 - $471,750
2,020 Added 31.75%
8,382 $1.92 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $867,445 - $1.12 Million
-5,279 Reduced 45.35%
6,362 $1.19 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $654,909 - $866,602
5,020 Added 75.82%
11,641 $1.97 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $968,122 - $1.12 Million
6,621 New
6,621 $980,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.